Could weight loss drug benefit patients living with alcohol addiction, liver disease and obesity?
August 21, 2026
August 21, 2026
LOUGHBOROUGH, England, Aug. 21 -- Loughborough University issued the following news release:
* * *
Could weight loss drug benefit patients living with alcohol addiction, liver disease and obesity?
*
Semaglutide, also known as Wegovy, works by mimicking the GLP-1 hormone and has been shown to slow digestion and suppress appetite. Now researchers are launching a trial to explore if it could be used to help people with alcohol dependency, obesity . . .
* * *
Could weight loss drug benefit patients living with alcohol addiction, liver disease and obesity?
*
Semaglutide, also known as Wegovy, works by mimicking the GLP-1 hormone and has been shown to slow digestion and suppress appetite. Now researchers are launching a trial to explore if it could be used to help people with alcohol dependency, obesity . . .